BRUSSELS (dpa-AFX) - The Switzerland market ended on a weak note on
Wednesday as investors largely stayed cautious and chose to lighten some
commitments ahead of a slew of crucial economic data from the U.S.

The benchmark SMI, which stayed weak right through the day's session, settled
with a loss of 98.41 points or 0.86% at 11,370.74, the day's low.

Shares of drugmaker Roche Holding ended down by 4.4% after the company reported
a 6% drop in first-quarter sales.

UBS Group drifted down nearly 3%. Partners Group, Lindt Spruengli, Zurich
Insurance Group, Julius Baer and Alcon lost 1.3 to 2%.

Swiss RE, Swisscom, Swatch Group and SIG Group ended lower by 0.9 to 1.1%. Lonza
Group, Swiss Life Holding, Kuehne & Nagel and VAT Group lost 0.5 to 0.7%.

Logitech International, Sika, Givaudan, SGS, Holcim and Schindler Ps gained 0.4
to 0.9%. Novartis, Straumann Holding and ABB ended marginally up.

On the economic front, a report from UBS & CFA Society said the Swiss investors'
sentiment index rose by 6.1 points from the previous month to 17.6 in April
2024, marking the highest reading since September 2021.



Copyright(c) 2024 RTTNews.com. All Rights Reserved

Copyright RTT News/dpa-AFX